3645 results for «566»
3645 results
Featured Research - Aortic valve (Part 5)
25 Nov 2024 – From PCR London Valves 2024
This session features a selection of research abstracts from PCR London Valves 2024, covering a wide range of topics related to aortic valve interventions. Explore insights on predicting pacemaker need after TAVI, the impact of commissural misalignment and leaflet laceration, long-term outcomes with different valve types,...
Featured cases - TAVI embolisation (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Explore a captivating collection of featured TAVI cases from PCR London Valves 2024. Witness the management of complex complications such as valve embolization, retrograde migration, and coronary sequestration. Discover innovative percutaneous retrieval techniques, cases of multiple valves in TAVI, and strategies for handling acute valve migration...
Featured Cases - TAVI embolisation (Part 2)
25 Nov 2024 – From PCR London Valves 2024
This session features a selection of challenging TAVI cases from PCR London Valves 2024, focusing on the management of TAVI embolization and unexpected events. Learn from real-world experiences on handling transcatheter aortic valve dislodgement, migration, and other complications, and discover innovative techniques for successful bailout strategies.
Featured cases - Paravalvular leak closure
24 Nov 2024 – From PCR London Valves 2024
Dive into a captivating session showcasing selected PCR London Valves 2024 clinical cases on paravalvular leak closure. Witness the use of a hybrid approach for aortic paravalvular leaks, the management of infective endocarditis complications, and the percutaneous treatment of complex malpositioned valves. Explore interventions to address...
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
